AstraZeneca competitors

AstraZeneca's competitors include Bayer, Bristol-Myers Squibb, ITBMed and Terns Pharmaceuticals
Add company...
AstraZeneca
AstraZeneca, a global pharmaceutical company, discovers, develops, manufactures and markets prescription medicines.
Bayer
Bayer is a multinational pharmaceutical and life sciences company.
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
ITBMed
ITBMed is a biopharmaceutical company developing specific immunomodulatory biologics for organ transplantation, stem cell transplantation, and gene therapy.
Terns Pharmaceuticals
Terns Pharmaceuticals is a biopharmaceutical company.
Founding Date
Founding Date
1999
Founding Date
1863
Founding Date
1887
Founding Date
N/A
Founding Date
2017
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Cambridge, GB HQ
Sydney, AU
Brussels, BE
Winnipeg, CA
Mississauga, CA
Montreal, CA
Windsor, CA
see more
Locations
Leverkusen, DE HQ
Pymble, AU
São Paulo, BR
Mississauga, CA
Shanghai, CN
Havana, CU
Guatemala, GT
see more
Locations
New York, US HQ
Lawrence Township, US
Bi, DE
Zug, CH
Braine L'alleud, BE
Hopewell, US
Devens, US
see more
Locations
HQ
Locations
San Mateo, US HQ
Employees
Employees
61,1002% increase
Employees
99,84514% decrease
Employees
23,7005% decrease
Employees
N/A
Employees
950% increase
Valuation ($)
Valuation ($)
96.2 b
Valuation ($)
113.3 b
Valuation ($)
99.7 b
Valuation ($)
N/A
Valuation ($)
N/A
Facebook likes
Facebook likes
25.6 k
Facebook likes
2.8 m
Facebook likes
120.2 k
Facebook likes
N/A
Facebook likes
N/A
Twitter followers
Twitter followers
141.3 k
Twitter followers
148.9 k
Twitter followers
120.8 k
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
£22.5b (FY, 2017)
Revenue (est.)
€46.8b (FY, 2016)
Revenue (est.)
$19.4b (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
£4.3b (FY, 2017)
Cost of goods
€20.3b (FY, 2016)
Cost of goods
$4.9b (FY, 2016)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
£18.1b (FY, 2017)
Gross profit
€26.5b (FY, 2016)
Gross profit
$14.5b (FY, 2016)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
£2.9b (FY, 2017)
Net income
€4.5b (FY, 2016)
Net income
$4.5b (FY, 2016)
Net income
N/A
Net income
N/A

Operating

Countries
Countries
100 (FY, 2016)
Countries
152 (FY, 2016)
Countries
N/A
Countries
N/A
Countries
N/A
Phase III Trials Products
Phase III Trials Products
27 (FY, 2016)
Phase III Trials Products
17 (FY, 2015)
Phase III Trials Products
8 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
132 (FY, 2016)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 67m (5 months ago)
Latest funding round
$ 30m (5 months ago)
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 15.5m
Total funding raised
$ 67m
Total funding raised
$ 30m
For sources of this data, please see the company profileDownload Excel

View company profiles

Bayer
HQ
Leverkusen, DE
Employees
99,845↓ 14% decrease

Bayer is a multinational pharmaceutical and life sciences company.

View company
Bristol-Myers Squibb
HQ
New York, US
Employees
23,700↓ 5% decrease

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

View company
ITBMed
HQ

ITBMed is a biopharmaceutical company developing specific immunomodulatory biologics for organ transplantation, stem cell transplantation, and gene therapy.

View company
Terns Pharmaceuticals
HQ
San Mateo, US
Employees
9↑ 50% increase

Terns Pharmaceuticals is a biopharmaceutical company.

View company